Rentokil Initial Reports Mixed FY25 Preliminary Results with Improved H2 Growth and Increased Termite Provision
summarizeSummary
Rentokil Initial reported mixed FY25 preliminary results, showing improved H2 organic growth and strong free cash flow, but statutory profits were significantly impacted by a $201 million increase in termite damage claims provision.
check_boxKey Events
-
Mixed Financial Performance for FY25
Group revenue increased by 4.4% to $6,908 million, with adjusted operating profit up 5.4% to $1,070 million. However, statutory operating profit decreased by 9.3% to $584 million, and statutory basic EPS fell by 16.3% to 11.49 cents, primarily due to one-off adjustments.
-
Significant Increase in Termite Damage Claims Provision
The company recorded an additional provision of $122 million for termite damage claims in the second half of 2025, bringing the total for the year to $201 million. The closing provision now stands at $384 million, with similar cash outflows expected in 2026.
-
Improved Operational Momentum and Strategic Progress
Organic revenue growth accelerated in H2 to 3.5% (from 1.6% in H1), with North America Pest Control Services showing a Q4 improvement to 2.6%. The company is on track to deliver its North America 2027 targets of $100 million cost reduction and above 20% operating margin.
-
Strong Free Cash Flow and Reduced Net Debt
Free cash flow increased by 24.5% to $615 million, with a conversion rate of 98%, exceeding guidance. The net debt to adjusted EBITDA ratio improved to 2.6x from 2.9x, and the total dividend per share increased by 3.0% to 12.39 cents.
auto_awesomeAnalysis
Rentokil Initial's preliminary full-year 2025 results present a mixed financial picture. While the company demonstrated strong operational improvements, including accelerated organic revenue growth in the second half, robust free cash flow generation, and reduced net debt, these positives are significantly offset by a substantial increase in the provision for termite damage claims. The additional $122 million provision in H2, bringing the total for FY25 to $201 million, materially impacted statutory operating profit and basic EPS, which saw declines. Investors will likely weigh the underlying business momentum and progress on North America strategic targets against the ongoing financial impact of these legacy claims. The neutral 2026 outlook, in line with market expectations, suggests stability but no immediate catalysts from guidance.
At the time of this filing, RTO was trading at $32.29 on NYSE in the Trade & Services sector, with a market capitalization of approximately $14.3B. The 52-week trading range was $19.60 to $33.46. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.